DJ-1 Plays an Important Role in Homoharringtonine-Induced Apoptosis of Imatinib-Resistant Chronic Myeloid Leukemia Cells

被引：0
|
作者：
Zhou, Xuan [1 ]
Xu, Na [1 ]
Li, Rong [2 ]
Li, Lin [1 ]
Ding, Li [1 ]
Lu, Qisi [1 ]
Li, Yulin [3 ]
Liu Xiaoli [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
    Hoyle, Martin
    Rogers, Gabriel
    Moxham, Tiffany
    Liu, Zulian
    Stein, Ken
    VALUE IN HEALTH, 2011, 14 (08) : 1057 - 1067
  • [42] AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells
    Nieborowska-Skorska, M.
    Flis, S.
    Skorski, T.
    LEUKEMIA, 2014, 28 (12) : 2416 - 2418
  • [43] Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure
    Onaka, Takashi
    Takahashi, Naoto
    Miura, Masatomo
    Yonezawa, Akihito
    Imada, Kazunori
    Sawada, Kenichi
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) : 451 - 451
  • [44] PATTERNS OF ABL KD MUTATION IN ASIAN PATIENTS WITH IMATINIB-RESISTANT CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
    Kim, H.
    Kim, S.
    Byeun, J.
    Lee, S.
    Kim, H.
    Kim, Yeo-Kyeoung
    Kwak, J.
    Yhim, H.
    Kim, S.
    Do, Y.
    Oh, S.
    Au, W.
    Park, J.
    Jootar, S.
    Kim, D.
    HAEMATOLOGICA, 2013, 98 : 295 - 295
  • [45] Role of Bruton's tyrosine kinase in imatinib resistant chronic myeloid leukemia cells
    Schmidlechner, L.
    Sebens, S.
    Vater, I.
    Nagel, I.
    Cascorbi, I.
    Kaehler, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S44 - S44
  • [46] Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2
    Xu, Bing
    Chen, Feili
    Liu, Yuejian
    Wang, Shiyun
    Li, Rongwei
    Dong, Huijuan
    Zha, Jie
    BLOOD, 2013, 122 (21)
  • [47] Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
    Ling Xu
    YuHong Lu
    Jing Lai
    Wei Yu
    YiKai Zhang
    ZhenYi Jin
    Yan Xu
    Jie Chen
    XianFeng Zha
    ShaoHua Chen
    LiJian Yang
    YangQiu Li
    Science China Life Sciences, 2015, 58 : 1276 - 1281
  • [48] Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
    XU Ling
    LU Yu Hong
    LAI Jing
    YU Wei
    ZHANG Yi Kai
    JIN Zhen Yi
    XU Yan
    CHEN Jie
    ZHA Xian Feng
    CHEN Shao Hua
    YANG Li Jian
    LI Yang Qiu
    Science China(Life Sciences), 2015, (12) : 1276 - 1281
  • [49] Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
    Neda Mosakhani
    Satu Mustjoki
    Sakari Knuutila
    Molecular Cytogenetics, 6
  • [50] Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
    Cortes, J.
    Kim, D-W
    Raffoux, E.
    Martinelli, G.
    Ritchie, E.
    Roy, L.
    Coutre, S.
    Corm, S.
    Hamerschlak, N.
    Tang, J-L
    Hochhaus, A.
    Khoury, H. J.
    Bruemmendorf, T. H.
    Michallet, M.
    Rege-Cambrin, G.
    Gambacorti-Passerini, C.
    Radich, J. P.
    Ernst, T.
    Zhu, C.
    Van Tornout, J. M. A.
    Talpaz, M.
    LEUKEMIA, 2008, 22 (12) : 2176 - 2183
12345